Avicanna, a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, said the USPTO has issued a patent covering its topical cannabinoid compositions for clear skin.
It covers a topical gel formulation that is comprised of cannabinoids in combination with antioxidants, anti-microbial agents, and anti-inflammatory agents and in reference to its potential in treating and preventing skin diseases and conditions including, but not limited to, acne, wrinkles, rosacea and erythema.
“We are delighted with the issuance of another USPTO patent as we continue to expand our intellectual property portfolio. We are excited about the potential of this patent that covers our composition that are in our commercial platforms and pharmaceutical pipeline,” said Avicanna CEO Aras Azadian in a statement.
